ArticleThe Journal of clinical investigation2017

Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma.

Michael Olvedy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.